Klinger Shannon Thyme — SEC insider filings
SEC reporting owner CIK 1866132. 52 insider filings on record with FilingPulse; latest filed 2026-09-08.
Transaction summary — filings shown
Covers the 50 most recent of 52 filings on record, filed 2022-03-03 to 2026-09-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 28 legs across 28 filings — 38,416 shares, $3,483,625 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 164.
- Largest priced transaction: sale of 5,178 shares @ $148.09 ($766,785) in Moderna, Inc., filed 2024-06-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Moderna, Inc. (MRNA) | Chief Legal Officer | 50 | — | 28 legs · 38,416 sh · $3,483,625 | 164 |
Insider filings — Klinger Shannon Thyme
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-08 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 11,797 · Tax withholding (F): 5,704 @ $148.87 · Option exercise (M): 11,797 (derivative) @ $0 | EDGAR |
| 2026-09-03 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 3,471 @ $30.96 · Sale (S): 3,471 @ $139.95 · Option exercise (M): 2,166 · Tax withholding (F): 1,048 @ $140.34 · Option exercise (M): 3,471 (derivative) @ $0 · Option exercise (M): 2,166 (derivative) @ $0 | EDGAR |
| 2026-08-31 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 774 · Tax withholding (F): 375 @ $149.66 · Option exercise (M): 329 · Tax withholding (F): 160 @ $142.77 · Option exercise (M): 774 (derivative) @ $0 · Option exercise (M): 329 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 3,471 @ $30.96 · Sale (S): 3,471 @ $50 · Option exercise (M): 11,798 · Tax withholding (F): 5,705 @ $51.59 · Option exercise (M): 3,471 (derivative) @ $0 · Option exercise (M): 11,798 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 2,165 · Tax withholding (F): 1,047 @ $47.19 · Option exercise (M): 2,165 (derivative) @ $0 | EDGAR |
| 2026-05-29 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 773 · Tax withholding (F): 374 @ $47.03 · Option exercise (M): 328 · Tax withholding (F): 159 @ $47.61 · Option exercise (M): 773 (derivative) @ $0 · Option exercise (M): 328 (derivative) @ $0 | EDGAR |
| 2026-03-06 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 11,797 · Tax withholding (F): 5,704 @ $57.80 · Option exercise (M): 11,797 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 233 · Tax withholding (F): 113 @ $51.71 · Option exercise (M): 329 · Tax withholding (F): 160 @ $51.71 · Option exercise (M): 774 · Tax withholding (F): 375 @ $51.71 · +11 more | EDGAR |
| 2026-02-13 | 4 | Moderna, Inc. (MRNA) | Grant/award (A): 2,630 @ $0 · Tax withholding (F): 1,334 @ $41.99 | EDGAR |
| 2025-12-08 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 47,190 · Tax withholding (F): 22,817 @ $25.49 · Option exercise (M): 47,190 (derivative) @ $0 | EDGAR |
| 2025-12-02 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 233 · Tax withholding (F): 113 @ $25.98 · Option exercise (M): 233 (derivative) @ $0 | EDGAR |
| 2025-12-01 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 773 · Tax withholding (F): 374 @ $24.75 · Option exercise (M): 329 · Tax withholding (F): 160 @ $25.01 · Option exercise (M): 773 (derivative) @ $0 · Option exercise (M): 329 (derivative) @ $0 | EDGAR |
| 2025-09-02 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 232 · Tax withholding (F): 113 @ $24.47 · Option exercise (M): 232 (derivative) @ $0 | EDGAR |
| 2025-08-29 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 774 · Tax withholding (F): 375 @ $24.73 · Option exercise (M): 329 · Tax withholding (F): 160 @ $25.10 · Option exercise (M): 774 (derivative) @ $0 · Option exercise (M): 329 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 1,139 · Tax withholding (F): 551 @ $26.12 · Option exercise (M): 1,139 (derivative) @ $0 | EDGAR |
| 2025-06-02 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 233 · Tax withholding (F): 113 @ $26.93 · Option exercise (M): 233 (derivative) @ $0 | EDGAR |
| 2025-05-29 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 773 · Tax withholding (F): 374 @ $26.26 · Option exercise (M): 328 · Tax withholding (F): 159 @ $26.76 · Option exercise (M): 773 (derivative) @ $0 · Option exercise (M): 328 (derivative) @ $0 | EDGAR |
| 2025-03-10 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 1,139 · Tax withholding (F): 551 @ $34.30 · Option exercise (M): 1,139 (derivative) @ $0 | EDGAR |
| 2025-03-03 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 233 · Tax withholding (F): 113 @ $31.09 · Option exercise (M): 329 · Tax withholding (F): 160 @ $31.09 · Option exercise (M): 233 (derivative) @ $0 · Option exercise (M): 329 (derivative) @ $0 · +2 more | EDGAR |
| 2025-02-28 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 3,094 · Tax withholding (F): 1,496 @ $33.58 · Option exercise (M): 2,653 · Tax withholding (F): 1,283 @ $33.58 · Option exercise (M): 3,094 (derivative) @ $0 · Option exercise (M): 2,653 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | Moderna, Inc. (MRNA) | Grant/award (A): 2,047 @ $0 · Tax withholding (F): 1,068 @ $30.93 | EDGAR |
| 2024-12-10 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 1,138 · Sale (S): 529 @ $44.68 · Option exercise (M): 1,138 (derivative) @ $0 | EDGAR |
| 2024-12-06 | 4 | Moderna, Inc. (MRNA) | Grant/award (A): 188,761 (derivative) @ $0 | EDGAR |
| 2024-12-04 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 232 · Sale (S): 112 @ $43.30 · Option exercise (M): 232 (derivative) @ $0 | EDGAR |
| 2024-12-02 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 329 · Option exercise (M): 2,652 · Sale (S): 1,418 @ $42.79 · Option exercise (M): 329 (derivative) @ $0 · Option exercise (M): 2,652 (derivative) @ $0 | EDGAR |
| 2024-09-10 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 1,139 · Sale (S): 551 @ $73.57 · Option exercise (M): 1,139 (derivative) @ $0 | EDGAR |
| 2024-09-04 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 233 · Sale (S): 114 @ $76.99 · Option exercise (M): 233 (derivative) @ $0 | EDGAR |
| 2024-08-30 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 329 · Sale (S): 162 @ $78.03 · Option exercise (M): 329 (derivative) @ $0 | EDGAR |
| 2024-08-29 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 2,652 · Sale (S): 1,319 @ $79.39 · Option exercise (M): 2,652 (derivative) @ $0 | EDGAR |
| 2024-06-11 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 1,139 · Option exercise (M): 9,108 · Sale (S): 5,178 @ $148.09 · Option exercise (M): 1,139 (derivative) @ $0 · Option exercise (M): 9,108 (derivative) @ $0 | EDGAR |
| 2024-06-04 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 232 · Sale (S): 122 @ $140.72 · Option exercise (M): 232 (derivative) @ $0 | EDGAR |
| 2024-05-30 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 328 · Sale (S): 183 @ $144.50 · Option exercise (M): 328 (derivative) @ $0 | EDGAR |
| 2024-05-29 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 2,652 · Sale (S): 1,296 @ $162.47 · Option exercise (M): 2,652 (derivative) @ $0 | EDGAR |
| 2024-03-11 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 1,138 · Sale (S): 544 @ $99.05 · Option exercise (M): 1,138 (derivative) @ $0 | EDGAR |
| 2024-03-05 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 233 · Sale (S): 117 @ $94.34 · Option exercise (M): 233 (derivative) @ $0 | EDGAR |
| 2024-03-01 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 1,315 · Sale (S): 670 @ $94.57 · Option exercise (M): 1,315 (derivative) @ $0 | EDGAR |
| 2024-02-29 | 4 | Moderna, Inc. (MRNA) | Grant/award (A): 23,635 (derivative) @ $0 · Grant/award (A): 12,377 (derivative) @ $0 · Grant/award (A): 60,216 (derivative) @ $0 · Grant/award (A): 10,609 (derivative) @ $0 | EDGAR |
| 2023-12-11 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 1,139 · Sale (S): 563 @ $79.09 · Option exercise (M): 1,139 (derivative) @ $0 | EDGAR |
| 2023-12-05 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 232 · Sale (S): 111 @ $79.31 · Option exercise (M): 232 (derivative) @ $0 | EDGAR |
| 2023-09-11 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 1,138 · Sale (S): 557 @ $107.22 · Option exercise (M): 1,138 (derivative) @ $0 | EDGAR |
| 2023-09-06 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 233 · Sale (S): 115 @ $111.44 · Option exercise (M): 233 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 1,139 · Sale (S): 565 @ $124.09 · Option exercise (M): 1,139 (derivative) @ $0 | EDGAR |
| 2023-06-05 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 232 · Sale (S): 110 @ $130.32 · Option exercise (M): 232 (derivative) @ $0 | EDGAR |
| 2023-03-09 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 1,138 @ $0 · Sale (S): 561 @ $141.51 · Option exercise (M): 1,138 (derivative) @ $0 | EDGAR |
| 2023-03-03 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 930 @ $0 · Sale (S): 459 @ $136.43 · Option exercise (M): 930 (derivative) @ $0 | EDGAR |
| 2023-03-02 | 4 | Moderna, Inc. (MRNA) | Grant/award (A): 20,040 (derivative) @ $0 · Grant/award (A): 5,260 (derivative) @ $0 | EDGAR |
| 2022-12-09 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 1,139 @ $0 · Sale (S): 490 @ $179.15 · Option exercise (M): 1,139 (derivative) @ $0 | EDGAR |
| 2022-09-09 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 1,138 @ $0 · Sale (S): 478 @ $137.44 · Option exercise (M): 1,138 (derivative) @ $0 | EDGAR |
| 2022-06-09 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 4,554 @ $140 · Sale (S): 1,265 @ $148.12 · Option exercise (M): 4,554 (derivative) @ $0 | EDGAR |
| 2022-03-03 | 4 | Moderna, Inc. (MRNA) | Grant/award (A): 15,091 (derivative) @ $0 · Grant/award (A): 3,721 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-06-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1866132 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs